Mostrar el registro sencillo del ítem

dc.contributor.authorIzarra, Alberto 
dc.contributor.authorMoscoso, Isabel 
dc.contributor.authorLevent, Elif
dc.contributor.authorCanon, Susana 
dc.contributor.authorCerrada, Inmaculada
dc.contributor.authorDiez-Juan, Antonio 
dc.contributor.authorBlanca, Vanessa 
dc.contributor.authorNunez-Gil, Ivan-J.
dc.contributor.authorValiente, Iñigo 
dc.contributor.authorRuiz-Sauri, Amparo
dc.contributor.authorSepulveda, Pilar
dc.contributor.authorTiburcy, Malte
dc.contributor.authorZimmermann, Wolfram-H.
dc.contributor.authorBernad, Antonio 
dc.date.accessioned2017-12-01T07:37:28Z
dc.date.available2017-12-01T07:37:28Z
dc.date.issued2014
dc.identifierISI:000346159300010
dc.identifier.citationStem Cell Reports. 2014; 3(6):1029-42
dc.identifier.issn2213-6711
dc.identifier.urihttp://hdl.handle.net/20.500.12105/5533
dc.description.abstractmiR-133a and miR-1 are known as muscle-specific microRNAs that are involved in cardiac development and pathophysiology. We have shown that both miR-1 and miR-133a are early and progressively upregulated during in vitro cardiac differentiation of adult cardiac progenitor cells (CPCs), but only miR-133a expression was enhanced under in vitro oxidative stress. miR-1 was demonstrated to favor differentiation of CPCs, whereas miR-133a overexpression protected CPCs against cell death, targeting, among others, the proapoptotic genes Bim and Bmf. miR-133a-CPCs clearly improved cardiac function in a rat myocardial infarction model by reducing fibrosis and hypertrophy and increasing vascularization and cardiomyocyte proliferation. The beneficial effects of miR-133a-CPCs seem to correlate with the upregulated expression of several relevant paracrine factors and the plausible cooperative secretion of miR-133a via exosomal transport. Finally, an in vitro heart muscle model confirmed the antiapoptotic effects of miR-133a-CPCs, favoring the structuration and contractile functionality of the artificial tissue.
dc.description.sponsorshipThis work was supported by grants to A.B. from the Ministry of Economy and Competition (SAF2012-3432, PLE2009-0147, and PSE-010000-2009-3), the Comunidad Autonoma de Madrid (S2011/BMD-2420), ISCIII (RD12/0019/0018). W.-H.Z. is supported by the DZHK (German Center for Cardiovascular Research), the German Federal Ministry for Science and Education (BMBF FKZ 13GW0007A, joint program with the California Institute of Renerative Medicine), the German Research Foundation (DFG ZI 708/7-1, 8-1, 10-1, SFB 1002 TP C04 and TP S), and the NIH (U01 HL099997). A.B. and W.-H.Z. have been both supported by the European Commission (FP7-HEALTH-2009/CARE-MI). A.I. and I. M. were postdoctoral fellows funded by the Ministry of Economy and Competition. S.C. is a contracted scientist funded by ISCIII. The CNIC and CNB are supported by the Ministry of Economy and Competition. We thank Iria Sanchez, Tamara Cordoba, Erica Lopez, and Carmen Albo for technical help, Candelas Carreiro for logistics support, Marta Ramon for secretarial assistance, and Kenneth McCreath for help with manuscript editing.
dc.language.isoeng
dc.publisherCell Press 
dc.type.hasVersionVoR
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectENGINEERED HEART-TISSUE
dc.subjectEMBRYONIC STEM-CELLS
dc.subjectOXIDATIVE STRESS
dc.subjectMUSCLE
dc.subjectDIFFERENTIATION
dc.subjectMICRORNA
dc.subjectHYPERTROPHY
dc.subjectAPOPTOSIS
dc.subjectGROWTH
dc.subjectREGENERATION
dc.titlemiR-133a Enhances the Protective Capacity of Cardiac Progenitors Cells after Myocardial Infarction
dc.typejournal article
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.identifier.pubmedID25465869
dc.format.volume3
dc.format.page1029-1042
dc.identifier.doi10.1016/j.stemcr.2014.10.010
dc.contributor.funderMinisterio de Economía y Competitividad (España) 
dc.contributor.funderComunidad de Madrid (España) 
dc.contributor.funderInstituto de Salud Carlos III 
dc.contributor.funderGerman Centre for Cardiovascular Research 
dc.contributor.funderDeutsche Forschungsgemeinschaft (Alemania) 
dc.contributor.funderNational Institutes of Health (Estados Unidos) 
dc.contributor.funderUnión Europea. Comisión Europea 
dc.description.peerreviewed
dc.relation.publisherversionhttps://doi.org/10.1016/j.stemcr.2014.10.010
dc.identifier.journalStem Cell Reports
dc.repisalud.orgCNICCNIC::Grupos de investigación::Antiguos CNIC
dc.repisalud.institucionCNIC
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/184176es_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail
Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Attribution-NonCommercial-NoDerivatives 4.0 Internacional